U.S., Feb. 12 -- ClinicalTrials.gov registry received information related to the study (NCT06819241) titled 'Self-Management of Blood Pressure in Resistant Hypertension' on Jan. 13.
Brief Summary: The trial is a 12-month randomized, parallel-group study comparing three arms: (1) HBP self-management with AI chatbot support, (2) HBP self-management without AI chatbot support, and (3) usual care. The primary objective is to evaluate differences in blood pressure changes and medication compliance between groups at 6 and 12 months.
Study Start Date: Feb. 16
Study Type: INTERVENTIONAL
Condition:
Resistant Hypertension
Intervention:
BEHAVIORAL: AI chatbot support
Integrating the practice of self-monitoring of HBP with the use of AI chatbot...